ConductScience.org, home

Trial · NCT07899567

Effects of Pastel Nagomi Art on Psychological Well-Being in Nursing Students

NCT07899567, Not applicable, Completed, Min-Hwei Junior College of Health Care Management

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Effects of Pastel Nagomi Art on Psychological Well-Being in Nursing Students. Trials, record NCT07899567. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07899567

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Effects of Pastel Nagomi Art on Psychological Well-Being in Nursing Students
NCT number
NCT07899567
Status
Completed
Phases
Not applicable
Enrollment
101 participants, actual
Lead sponsor
Min-Hwei Junior College of Health Care Management
Conditions
Psychological Well-being, Resilience, Nursing Students, Depression
Interventions
Pastel Nagomi Art Workshop
First posted
2026-10-27
Last updated
2026-10-27

Source ClinicalTrials.gov

Registered outcomes3

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryChange from Baseline in Center for Epidemiologic Studies Depression Scale (CES-D) Score at Week4 and 8.Baseline (week 0) and post-intervention (weeks 4 and 8)
Depressive symptoms were assessed using the Chinese version of the Center for Epidemiologic Studies Depression Scale (CES-D). The scale consists of 20 items, each rated on a 4-point Likert scale ranging from 0 (rarely or none of the time) to 3 (most or all of the time). Total scores range from 0 to 60, with higher scores indicating greater severity of depressive symptoms.
PrimaryChange from Baseline in Inventory of Adolescent Resilience (IAR) Total Score at Week4 and 8Baseline (week 0) and post-intervention (weeks 4 and 8)
Resilience was assessed using the Inventory of Adolescent Resilience (IAR). The 28-item scale evaluates four domains: problem-solving and cognitive maturity, hope and optimism, empathy and interpersonal interaction, and emotional regulation. Items are rated on a 4-point Likert scale ranging from 1 (very inconsistent) to 4 (very consistent). Total scores range from 28 to 112, with higher scores indicating greater resilience.
PrimaryChange from Baseline in Trait Hope Scale (THS) Total Score at Week4 and 8.Baseline (week 0) and post-intervention (weeks 4 and 8)
Hope was assessed using the Chinese version of the Trait Hope Scale (THS). The 12-item scale consists of two core subscales (Agency and Pathways) and distractor items (not scored). Items are rated on an 8-point Likert scale ranging from 1 (definitely false) to 8 (definitely true). Total scores range from 8 to 64, with higher scores indicating greater trait hope and more positive expectations for the future.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07899567

GET https://conductscience.org/api/trials/v1/NCT07899567/registered